Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07822581) titled '"Discovery2" Study of Using MCG at Emergency Departments' on Sept. 1.
Study Type: Observational
Primary Sponsor: SB Technology, Inc.
Condition:
Acute Coronary Syndromes (ACS)
Coronary Artery Disease (CAD)
Chest Pain
NSTE-ACS (NSTEMI and UA)
Intervention:
Device: Magnetocardiography
Recruitment Status: Not recruiting
Date of First Enrollment: September 1, 2026
Target Sample Size: 200
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07822581
Disclaimer: Curated by HT Syndication....